152 related articles for article (PubMed ID: 6127861)
1. The comparative multiple-dose intraocular pressure responses of nadolol and timolol in glaucoma and ocular hypertension.
Krieglstein GK; Mohamed J
Acta Ophthalmol (Copenh); 1982 Apr; 60(2):284-92. PubMed ID: 6127861
[TBL] [Abstract][Full Text] [Related]
2. Diacetyl nadolol: 3-month ocular hypotensive effect in glaucomatous eyes.
Duzman E; Rosen N; Lazar M
Br J Ophthalmol; 1983 Oct; 67(10):668-73. PubMed ID: 6137236
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy of orally and topically administered beta blockers for chronic simple glaucoma.
Williamson J; Young JD; Atta H; Muir G; Kadom H
Br J Ophthalmol; 1985 Jan; 69(1):41-5. PubMed ID: 2856893
[TBL] [Abstract][Full Text] [Related]
4. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
Reis R; Queiroz CF; Santos LC; Avila MP; Magacho L
Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466
[TBL] [Abstract][Full Text] [Related]
5. Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: a prospective, randomized, double-masked, active-controlled, three-period crossover pilot study.
Sonty S; Mundorf TK; Stewart JA; Stewart WC
Clin Ther; 2009 Oct; 31(10):2063-71. PubMed ID: 19922877
[TBL] [Abstract][Full Text] [Related]
6. Latanoprost : an update of its use in glaucoma and ocular hypertension.
Perry CM; McGavin JK; Culy CR; Ibbotson T
Drugs Aging; 2003; 20(8):597-630. PubMed ID: 12795627
[TBL] [Abstract][Full Text] [Related]
7. Diacetyl derivative of nadolol. I. Ocular pharmacology and short-term ocular hypotensive effect in glaucomatous eyes.
Duzman E; Chen CC; Anderson J; Blumenthal M; Twizer H
Arch Ophthalmol; 1982 Dec; 100(12):1916-9. PubMed ID: 6756362
[TBL] [Abstract][Full Text] [Related]
8. A comparison of betaxolol and timolol in open angle glaucoma and ocular hypertension.
Feghali JG; Kaufman PL; Radius RL; Mandell AI
Acta Ophthalmol (Copenh); 1988 Apr; 66(2):180-6. PubMed ID: 2898859
[TBL] [Abstract][Full Text] [Related]
9. Twelve-month results of an ongoing randomized trial comparing brimonidine tartrate 0.2% and timolol 0.5% given twice daily in patients with glaucoma or ocular hypertension. Brimonidine Study Group 2.
LeBlanc RP
Ophthalmology; 1998 Oct; 105(10):1960-7. PubMed ID: 9787370
[TBL] [Abstract][Full Text] [Related]
10. Effects of systemic beta-blocker therapy on the efficacy and safety of topical brimonidine and timolol. Brimonidine Study Groups 1 and 2.
Schuman JS
Ophthalmology; 2000 Jun; 107(6):1171-7. PubMed ID: 10857839
[TBL] [Abstract][Full Text] [Related]
11. Nadolol eye drops in glaucoma and ocular hypertension: a controlled clinical study of dose response and duration of action.
Krieglstein GK
Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1981; 217(4):309-14. PubMed ID: 6119925
[TBL] [Abstract][Full Text] [Related]
12. Phase III long-term study and comparative clinical study of nipradilol ophthalmic solution in patients with primary open-angle glaucoma and ocular hypertension.
Kanno M; Araie M; Masuda K; Takase M; Kitazawa Y; Shiose Y; Azuma I; Ogawa N; Ohdo S
Arzneimittelforschung; 2006; 56(11):729-34. PubMed ID: 17220049
[TBL] [Abstract][Full Text] [Related]
13. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group.
Camras CB
Ophthalmology; 1996 Jan; 103(1):138-47. PubMed ID: 8628544
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the intraocular pressure lowering effect of latanoprost and a fixed combination of timolol-pilocarpine eye drops in patients insufficiently controlled with beta adrenergic antagonists. French Latanoprost Study Group, and the Swedish Latanoprost Study Group.
Nordmann JP; Söderström M; Rouland JF; Malecaze F
Br J Ophthalmol; 2000 Feb; 84(2):181-5. PubMed ID: 10655195
[TBL] [Abstract][Full Text] [Related]
15. Latanoprostene Bunod 0.024% versus Timolol Maleate 0.5% in Subjects with Open-Angle Glaucoma or Ocular Hypertension: The APOLLO Study.
Weinreb RN; Scassellati Sforzolini B; Vittitow J; Liebmann J
Ophthalmology; 2016 May; 123(5):965-73. PubMed ID: 26875002
[TBL] [Abstract][Full Text] [Related]
16. A comparison of dorzolamide and timolol in patients with pseudoexfoliation and glaucoma or ocular hypertension.
Heijl A; Strahlman E; Sverrisson T; Brinchman-Hansen O; Puustjärvi T; Tipping R
Ophthalmology; 1997 Jan; 104(1):137-42. PubMed ID: 9022118
[TBL] [Abstract][Full Text] [Related]
17. A comparison of latanoprost and timolol in primary open-angle glaucoma and ocular hypertension. A 12-week study.
Mishima HK; Masuda K; Kitazawa Y; Azuma I; Araie M
Arch Ophthalmol; 1996 Aug; 114(8):929-32. PubMed ID: 8694726
[TBL] [Abstract][Full Text] [Related]
18. Nadolol and labetalol: comparative efficacy of two beta-blocking agents in glaucoma.
Krieglstein GK; Kontić D
Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1981; 216(4):313-7. PubMed ID: 6114677
[TBL] [Abstract][Full Text] [Related]
19. Effects of Topical Bimatoprost 0.01% and Timolol 0.5% on Circadian IOP, Blood Pressure and Perfusion Pressure in Patients with Glaucoma or Ocular Hypertension: A Randomized, Double Masked, Placebo-Controlled Clinical Trial.
Oddone F; Rossetti L; Tanga L; Berardo F; Ferrazza M; Michelessi M; Roberti G; Manni G; Centofanti M
PLoS One; 2015; 10(10):e0140601. PubMed ID: 26484767
[TBL] [Abstract][Full Text] [Related]
20. One-year, randomized study comparing bimatoprost and timolol in glaucoma and ocular hypertension.
Higginbotham EJ; Schuman JS; Goldberg I; Gross RL; VanDenburgh AM; Chen K; Whitcup SM;
Arch Ophthalmol; 2002 Oct; 120(10):1286-93. PubMed ID: 12365906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
